Company Information

Company Name
Geneius Biotech
Company Description
Geneius, led by a world-class team of T-cell experts, has developed a best-in-class personalized, adoptive T cell therapy platform that generates a more robust immune response to cancer compared with CAR-Tand TILs with a significantly lower cost, increased accessibility, and no toxicity.
Industry Type
BioTherapy
Incoming Channel

Contact Information

CEO
Alfred Slanetz, Ph.D., M.E
COO
Wayne Froland, Ph.D
CFO
CTO
CMO
CCO